Tg is commonly used as a biomarker for thyroid dysfunction during pregnancy and in Graves’ disease; however, in the study by Kurimoto et al., serum Tg levels were also found to help distinguish patients more likely to develop IMTD (44, 45). The gene discussed is TG; the disease is Graves disease.